摘要:
The invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in preparing a medicinal product for the treatment and/or prophylaxis of rosacea.
摘要:
Derivado del ácido naftalensulfónico o quinolinsulfónico de fórmula (I) en donde A es N o un grupo de fórmula CR 8 , donde R 8 es H, OH, NR 10 R 11 , donde R 10 y R 11 , independientemente entre sí, representan H, o alquilo C 1 -C 6 , o un grupo de fórmula NH-CO-R 12 , donde R 12 es alquilo C 1 -C 6 o arilo C 6 -C 10 ; R 1 y R 2 representan, independientemente entre sí, H o SO 3 R 9 , donde R 9 es H, amonio o un catión de un metal alcalino o alcalinotérreo; R 3 es H u OH; y R 4 , R 5 , R 6 y R 7 , independientemente entre sí, representan H, un grupo NR 10 R 11 o NH-CO-R 12 ; con la condición de que (i) al menos uno de R 1 o R 2 es SO 3 R 9 , y (ii) al menos uno de R 4 , R 5 , R 6 o R 7 es un grupo NR 10 R 11 o NH-CO-R 12 , o sus sales farmacéuticamente aceptables; y un excipiente farmacéuticamente aceptable.
摘要翻译:本发明涉及具有式(I)的萘磺酸或喹啉磺酸的衍生物,其中:A为N或式CR 8的基团,其中R 8为H,OH,NR 10 R 11 其中R 10和R 11彼此独立地表示H或C 1 -C 6烷基或具有式NH-CO-R 12的基团,其中R 12是C 1 -C 6 烷基或C6-C10芳基; R 1和R 2彼此独立地表示H或SO 3 R 9,其中R 9是H,铵或碱金属或碱土金属的阳离子; R 3是H或OH; R 4,R 5,R 6和R 7彼此独立地表示H,NR 10 R 11或NH-CO-R 12基团 在(i)至少R 1或R 2为SO 3 R 9的情况下,和(ii)至少R 4,R 5,R 6或R 7, 是NR 10 R 11基团或NH-CO-R 12基团,或其药学上可接受的盐。 本发明还涉及药学上可接受的赋形剂。
摘要:
The invention relates to the use of fibroblast growth factor and its derivatives as neuroprotective agents against the damage produced by ischaemia and cerebral reperfusion, and as agents with a neuromodulatory effect on motor activity, and of all compounds related thereto, in those clinical situations which require neuronal protection following cerebral or carotid ischaemia. The pharmacological use of acidic and basic fibroblast growth factor and all compounds relating thereto is also justified in clinical situations which require a decrease in agitation and aggressiveness.
摘要:
The present invention relates to nitrosated derivatives of 2,5- dihydroxybenzene compounds that are useful in the preparation of medicinal products for the treatment of different diseases. The diseases in question are, in particular: (a) cancer; (b) rosacea; (c) psoriasis; (d) fibrosis; (e) hemangiomas; (f) ocular diseases; (g) skin pigmentation and skin hyperpigmentation; (h) diseases associated with amyloidosis; (i) dermatitis; (j) actinic and seborrheic keratosis; (k) erectile dysfunction; (1) female sexual dysfunction; (m) arterial hypertension; (n) atherosclerosis; (o) inflammatory diseases in particular, arthritis, glomerulonephritis and asthma; (p) intestinal inflammatory diseases in particular, ulcerative colitis and Crohn's disease; (q) benign prostatic hyperplasia; (r) leishmaniasis; (s) angiogenesis associated to chronic temporal lobe epilepsy, (t) pain, (u) hyperlipidemia and (v) thrombosis.
摘要:
The present invention relates to the use of a compound of Formula (I') or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of any of the diseases selected from the group consisting of benign prostatic hyperplasia, Barrett's disease, asthma, skeletal muscle and tendon repair, Crohn's disease, ulcerative colitis and leishmaniasis.
摘要:
The present invention refers to the use of a compound of Formula (I') or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of hematological dyscrasias, including myelodysplastic syndromes (MDSs) and for improving the efficacy of chemotherapy, radiation therapy and/or cancer immunotherapy. In addition, it relates to the use of a compound of formula (I'') in the manufacturing of a medicament for the treatment and/or prophylaxis of cancer of an organ.
摘要:
The present invention relates to the use of a compound of Formula (I''') or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of arthritis and pain.
摘要:
The present invention relates to the use of a compound of Formula (I'') or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of any of the diseases selected from the group consisting of diseases associated to Helicobacter pylori infection, pterygium, endometrosis, ovarian hyperstimulation syndrome and polycystic kidney disease.
摘要:
The invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in preparing a medicinal product for the treatment and/or prophylaxis of psoriasis.
摘要:
The present invention relates to the use of a 2,5-dihydroxybenzene derivative represented by Formula (I) or a pharmaceutically acceptable salt or solvate thereof, isomer or prodrug thereof to prepare a medicament for the therapeutic and/or prophylactic treatment of actinic keratosis.